GlassScriptPhysician profile
Kevin Charles
NPI 1649616558
$772.96
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2021: $62.64 · 2022: $26.33 · 2023: $26.40 · 2024: $127 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $251.21 | 2019-2024 | Giapreza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.66 | 2019-2022 | |
| Grifols USA, LLC | $50.53 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $44.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.72 | 2025 | Lifevest |
| Pfizer INC. | $37.76 | 2019 | |
| Becton, Dickinson and Company | $35.46 | 2025 | Powerglide |
| Abbvie INC. | $34.73 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $31.23 | 2019 | |
| Bard Access Systems, INC. | $27.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $27.37 | 2019 | |
| Mylan Specialty L.P. | $26.40 | 2023 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.83 | 2019 | |
| Insmed, INC. | $16.24 | 2021 | |
| Glaxosmithkline, LLC. | $13.66 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.41 | 2019 | |
| Merck Sharp & Dohme LLC | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.